Qatar Blood-based Biomaker For Sports Medicine Market Size & Outlook
Qatar blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Qatar blood-based biomaker for sports medicine market highlights
- The Qatar blood-based biomaker for sports medicine market generated a revenue of USD 1.0 million in 2023 and is expected to reach USD 1.6 million by 2030.
- The Qatar market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- IL-6 is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 1.0 million |
| Market revenue in 2030 | USD 1.6 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | IL-6 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Qatar accounted for 0.1% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 6.7 million by 2030.
Ck was the largest segment with a revenue share of 20% in 2023. Horizon Databook has segmented the Qatar blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Qatar has significantly enhanced its sports infrastructure in preparation for the FIFA World Cup 2022, investing over USD 300 billion in various infrastructure projects. This substantial expenditure has led to the construction of state-of-the-art stadiums, training facilities, and transportation networks, demonstrating Qatar’s commitment to hosting a world-class event.
The emphasis on advanced infrastructure reflects the country’s broader strategy to boost sports participation and performance. As the country invests in sports facilities and events, the focus on incorporating cutting-edge medical technologies like blood-based biomarkers highlights Qatar's dedication to enhancing athlete care and performance.
A study published in August 2024 highlighted a significant incidence of injuries among Qatar Stars League (QSL) players, with a total of 4,789 injuries recorded. Re-injuries were a significant concern, accounting for 10.8% of all injuries. This highlights the urgent need for better rehabilitation and monitoring methods and emphasizes the growing importance of advanced medical technology in sports medicine.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Qatar blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Qatar Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
